- Home
- TNGX vs SFHG Comparison
TNGX vs SFHG Comparison
Compare TNGX & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- SFHG
- Stock Information
- Founded
- TNGX 2014
- SFHG 1993
- Country
- TNGX United States
- SFHG Hong Kong
- Employees
- TNGX N/A
- SFHG N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- SFHG Publishing
- Sector
- TNGX Health Care
- SFHG Consumer Discretionary
- Exchange
- TNGX Nasdaq
- SFHG Nasdaq
- Market Cap
- TNGX 351.2M
- SFHG 16.6M
- IPO Year
- TNGX N/A
- SFHG 2024
- Fundamental
- Price
- TNGX $6.01
- SFHG $0.93
- Analyst Decision
- TNGX Strong Buy
- SFHG
- Analyst Count
- TNGX 6
- SFHG 0
- Target Price
- TNGX $12.20
- SFHG N/A
- AVG Volume (30 Days)
- TNGX 2.7M
- SFHG 50.4K
- Earning Date
- TNGX 08-06-2025
- SFHG 07-15-2025
- Dividend Yield
- TNGX N/A
- SFHG N/A
- EPS Growth
- TNGX N/A
- SFHG N/A
- EPS
- TNGX N/A
- SFHG N/A
- Revenue
- TNGX $40,990,000.00
- SFHG $19,760,935.00
- Revenue This Year
- TNGX N/A
- SFHG N/A
- Revenue Next Year
- TNGX N/A
- SFHG N/A
- P/E Ratio
- TNGX N/A
- SFHG N/A
- Revenue Growth
- TNGX 10.09
- SFHG 30.89
- 52 Week Low
- TNGX $1.03
- SFHG $0.55
- 52 Week High
- TNGX $12.02
- SFHG $24.00
- Technical
- Relative Strength Index (RSI)
- TNGX 76.36
- SFHG N/A
- Support Level
- TNGX $5.34
- SFHG N/A
- Resistance Level
- TNGX $6.40
- SFHG N/A
- Average True Range (ATR)
- TNGX 0.50
- SFHG 0.00
- MACD
- TNGX -0.02
- SFHG 0.00
- Stochastic Oscillator
- TNGX 84.08
- SFHG 0.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.